Skip to main content
NCBI home page
Annals of Surgery logoLink to Annals of Surgery
. 1971 Oct;174(4):620–639. doi: 10.1097/00000658-197110000-00008

Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen.

M Torisu, T Yokoyama, H Amemiya, P F Kohler, G Schroter, G Martineau, I Penn, W Palmer, C G Halgrimson, C W Putnam, T E Starzl
PMCID: PMC1397685  PMID: 4999690

Full text

PDF
620

Images in this article

628Fig. 7.
on p.628
630Fig. 8.
on p.630

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. D., Waterson A. P. Immune complexes in hepatitis. Lancet. 1969 Nov 8;2(7628):983–986. doi: 10.1016/s0140-6736(69)90540-6. [DOI] [PubMed] [Google Scholar]
  2. Alper C. A., Johnson A. M., Birtch A. G., Moore F. D. Human C'3: evidence for the liver as the primary site of synthesis. Science. 1969 Jan 17;163(3864):286–288. doi: 10.1126/science.163.3864.286. [DOI] [PubMed] [Google Scholar]
  3. BERENBAUM M. C., BROWN I. N. PROLONGATION OF HOMOGRAFT SURVIVAL IN MICE WITH SINGLE DOSES OF CYCLOPHOSPHAMIDE. Nature. 1963 Oct 5;200:84–84. doi: 10.1038/200084a0. [DOI] [PubMed] [Google Scholar]
  4. BLUMBERG B. S., ALTER H. J., VISNICH S. A "NEW" ANTIGEN IN LEUKEMIA SERA. JAMA. 1965 Feb 15;191:541–546. doi: 10.1001/jama.1965.03080070025007. [DOI] [PubMed] [Google Scholar]
  5. BUSSARD A. [Description of a technic simultaneously combining electrophoresis and immunological precipitation in gel: electrosyneresis]. Biochim Biophys Acta. 1959 Jul;34:258–260. doi: 10.1016/0006-3002(59)90261-6. [DOI] [PubMed] [Google Scholar]
  6. Barker L. F., Shulman N. R., Murray R., Hirschman R. J., Ratner F., Diefenbach W. C., Geller H. M. Transmission of serum hepatitis. JAMA. 1970 Mar 2;211(9):1509–1512. [PubMed] [Google Scholar]
  7. Bayer M. E., Blumberg B. S., Werner B. Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis. Nature. 1968 Jun 15;218(5146):1057–1059. doi: 10.1038/2181057a0. [DOI] [PubMed] [Google Scholar]
  8. Blumberg B. S., Friedlaender J. S., Woodside A., Sutnick A. I., London W. T. Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans. Proc Natl Acad Sci U S A. 1969 Apr;62(4):1108–1115. doi: 10.1073/pnas.62.4.1108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Blumberg B. S., Gerstley B. J., Hungerford D. A., London W. T., Sutnick A. I. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med. 1967 May;66(5):924–931. doi: 10.7326/0003-4819-66-5-924. [DOI] [PubMed] [Google Scholar]
  10. Blumberg B. S., Melartin L. Australia antigen and hepatitis. Studies in asymptomatic people and lepromatous leprosy patient. Arch Intern Med. 1970 Feb;125(2):287–292. doi: 10.1001/archinte.125.2.287. [DOI] [PubMed] [Google Scholar]
  11. Blumberg B. S., Melartin L., Lechat M., Guinto R. S. Association between lepromatous leprosy and Australia antigen. Lancet. 1967 Jul 22;2(7508):173–176. doi: 10.1016/s0140-6736(67)90003-7. [DOI] [PubMed] [Google Scholar]
  12. Blumberg B. S., Sutnick A. I., London W. T. Australia antigen as a hepatitis virus. Variation in host response. Am J Med. 1970 Jan;48(1):1–8. doi: 10.1016/0002-9343(70)90093-8. [DOI] [PubMed] [Google Scholar]
  13. Blumberg B. S., Sutnick A. I., London W. T. Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med. 1968 Dec;44(12):1566–1586. [PMC free article] [PubMed] [Google Scholar]
  14. Blumberg B. S., Sutnick A. I., London W. T., Millman I. Australia antigen and hepatitis. N Engl J Med. 1970 Aug 13;283(7):349–354. doi: 10.1056/NEJM197008132830707. [DOI] [PubMed] [Google Scholar]
  15. Brody G. L., Jones J. W., Haines R. F. Influence of cyclophosphamide on homograft rejection. JAMA. 1965 Jan 25;191(4):297–300. [PubMed] [Google Scholar]
  16. COOPER R. G. ANTICOMPLEMENTARY PHENOMENA IN MONOCLONAL HYPERGLOBULINEMIA. J Lab Clin Med. 1964 Mar;63:404–415. [PubMed] [Google Scholar]
  17. Castanedo J. P., Williams R. C., Jr Anticomplementary activity of sera from patients with connective tissue disease and normal subjects. J Lab Clin Med. 1967 Feb;69(2):217–228. [PubMed] [Google Scholar]
  18. Chang L. W., O'Brien T. F. Australia antigen serology in the Holy Cross football team hepatitis outbreak. Lancet. 1970 Jul 11;1(7663):59–61. doi: 10.1016/s0140-6736(70)92636-x. [DOI] [PubMed] [Google Scholar]
  19. DONALDSON V. H., EVANS R. R. A BIOCHEMICAL ABNORMALITY IN HEREDIATRY ANGIONEUROTIC EDEMA: ABSENCE OF SERUM INHIBITOR OF C' 1-ESTERASE. Am J Med. 1963 Jul;35:37–44. doi: 10.1016/0002-9343(63)90162-1. [DOI] [PubMed] [Google Scholar]
  20. Doniach D., Walker J. G. A unified concept of autoimmune hepatitis. Lancet. 1969 Apr 19;1(7599):813–815. doi: 10.1016/s0140-6736(69)92072-8. [DOI] [PubMed] [Google Scholar]
  21. FOX M. SUPPRESSION OF TISSUE IMMUNITY BY CYCLOPHOSPHAMIDE. Transplantation. 1964 Jul;2:475–486. doi: 10.1097/00007890-196407000-00004. [DOI] [PubMed] [Google Scholar]
  22. FRISCH A. W., DAVIES G. H. INHIBITION OF HEMAGGLUTININ SYNTHESIS BY CYTOXAN. Cancer Res. 1965 Jun;25:745–751. [PubMed] [Google Scholar]
  23. GOODWIN W. E., KAUFMAN J. J., MIMS M. M., TURNER R. D., GLASSOCK R., GOLDMAN R., MAXWELL M. M. Human renal transplantation. I. Clinical experiences with six cases of renal homotransplantation. J Urol. 1963 Jan;89:13–24. doi: 10.1016/S0022-5347(17)64491-4. [DOI] [PubMed] [Google Scholar]
  24. Gust I. D., Cross G., Kaldor J., Ferris A. A. Virus-like particles in Australia-antigen-associated hepatitis. Lancet. 1970 May 2;1(7653):953–953. doi: 10.1016/s0140-6736(70)91082-2. [DOI] [PubMed] [Google Scholar]
  25. HEIMER R., LEVIN F. M., PRIMACK A., CORCOS J. M., NOSENZO C. Inhibition of complement fixation by human serum. J Immunol. 1962 Sep;89:382–390. [PubMed] [Google Scholar]
  26. Hamburger J., Crosnier J., Dormont J., Reveillaud R. J., Hors J. H., Alsina J. Homotransplantation rénale humaine. Résultats personnels chez 52 malades. 3. Complications extra-rénales--conclusions d'ensemble. Presse Med. 1965 Nov 27;73(51):2911–concl. [PubMed] [Google Scholar]
  27. Hume D. M., Lee H. M., Williams G. M., White H. J., Ferré J., Wolf J. S., Prout G. R., Jr, Slapak M., O'Brien J., Kilpatrick S. J. Comparative results of cadaver and related donor renal homografts in man, and immunologic implications of the outcome of second and paired transplants. Ann Surg. 1966 Sep;164(3):352–397. doi: 10.1097/00000658-196609000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. JONES J. W., BRODY G. L., ONEAL R. M., HAINES R. F. Prolongation of skin homografts in rabbits, using cyclophosphamide. J Surg Res. 1963 Jun;3:189–198. doi: 10.1016/s0022-4804(63)80057-8. [DOI] [PubMed] [Google Scholar]
  29. Kasukawa R., Yoshida T., Milgrom F. Inhibition of complement-mediated hemolysis by rheumatoid arthritis sera studies in agarose gel. Int Arch Allergy Appl Immunol. 1970;38(2):168–174. doi: 10.1159/000230269. [DOI] [PubMed] [Google Scholar]
  30. Krohn K., Finlayson N. D., Jokelainen P. T., Anderson K. E., Prince A. M. Electron microscopical and immunological observations on the serum-hepatitis (S.H.) antigen in primary biliary cirrhosis. Lancet. 1970 Aug 22;2(7669):379–383. doi: 10.1016/s0140-6736(70)90001-2. [DOI] [PubMed] [Google Scholar]
  31. Kunst V. A., Rosier J. G. Au antigen in at-risk patients. Lancet. 1970 Feb 21;1(7643):423–424. doi: 10.1016/s0140-6736(70)91564-3. [DOI] [PubMed] [Google Scholar]
  32. London W. T., Di Figlia M., Sutnick A., Blumberg B. S. An epidemic of hepatitis in a chronic-hemodialysis unit. Australia antigen and differences in host response. N Engl J Med. 1969 Sep 11;281(11):571–578. doi: 10.1056/NEJM196909112811101. [DOI] [PubMed] [Google Scholar]
  33. Lous P., Olesen H., Skinhoj P. Hepatitis-associated (Au-SH) antigen determination in 10,000 patients in a Copenhagen general hospital. Lancet. 1970 Jul 18;2(7664):119–121. doi: 10.1016/s0140-6736(70)92700-5. [DOI] [PubMed] [Google Scholar]
  34. MAGUIRE H. C., Jr, MAIBACH H. I. Effect of cyclophosphoramide, 6-mercaptopurine, actinomycin D and vincaleukoblastine on the acquisition of delayed hypersensitivity (DNCB) contact dermatitis) in the guinea-pig. J Invest Dermatol. 1961 Nov;37:427–431. doi: 10.1038/jid.1961.138. [DOI] [PubMed] [Google Scholar]
  35. MERRILL D. A., KIRKPATRICK C. H., WILSON W. E., RILEY C. M. CHANGE IN SERUM HAPTOGLOBIN TYPE FOLLOWING HUMAN LIVER TRANSPLANTATION. Proc Soc Exp Biol Med. 1964 Jul;116:748–751. doi: 10.3181/00379727-116-29363. [DOI] [PubMed] [Google Scholar]
  36. MOSLEY J. W. THE SURVEILLANCE OF TRANSFUSION-ASSOCIATED VIRAL HEPATITIS. JAMA. 1965 Sep 20;193:1007–1010. doi: 10.1001/jama.1965.03090120015004. [DOI] [PubMed] [Google Scholar]
  37. McPhaul J. J., Jr, Dixon F. J., Brettschneider L., Starzl T. E. Immunofluorescent examination of biopsies from long-term renal allografts. N Engl J Med. 1970 Feb 19;282(8):412–417. doi: 10.1056/NEJM197002192820802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Merrill D. A., Kohler P. F., Singleton J. W. Quantitation of the hepatitis-associated antigen by electroimmunodiffusion. J Allergy. 1971 Jun;47(6):315–320. doi: 10.1016/s0091-6749(71)80135-5. [DOI] [PubMed] [Google Scholar]
  39. Millman I., Loeb L. A., Bayer M. E., Blumberg B. S. Australia antigen (a hepatitis-associated antigen): purification and physical properties. J Exp Med. 1970 Jun 1;131(6):1190–1199. doi: 10.1084/jem.131.6.1190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Moncrieff M. W., White R. H., Oggs C. S., Cameron J. S. Cyclophosphamide therapy in the nephrotic syndrome in childhood. Br Med J. 1969 Mar 15;1(5645):666–671. doi: 10.1136/bmj.1.5645.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nowoslawski A., Brzosko W. J., Madaliński K., Krawczyński K. Cellular localisation of Australia antigen in the liver of patients with lymphoproliferative disorders. Lancet. 1970 Mar 7;1(7645):494–498. doi: 10.1016/s0140-6736(70)91580-1. [DOI] [PubMed] [Google Scholar]
  42. OUCHTERLONY O. Diffusion-in-gel methods for immunological analysis. Prog Allergy. 1958;5:1–78. [PubMed] [Google Scholar]
  43. Oldstone M. B., Dixon F. J. Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med. 1969 Mar 1;129(3):483–505. doi: 10.1084/jem.129.3.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Parsons F. M., Fox M., Anderson C. K., Markland C., Clark P. B., Raper F. P. Cyclophosphamide in renal homotransplantation. Br J Urol. 1966 Dec;38(6):673–676. doi: 10.1111/j.1464-410x.1966.tb09776.x. [DOI] [PubMed] [Google Scholar]
  45. Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814–821. doi: 10.1073/pnas.60.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Prince A. M., Burke K. Serum hepatitis antigen (SH): rapid detection by high voltage immunoelectroosmophoresis. Science. 1970 Aug 7;169(3945):593–595. doi: 10.1126/science.169.3945.593. [DOI] [PubMed] [Google Scholar]
  47. Purcell R. H., Holland P. V., Walsh J. H., Wong D. C., Morrow A. G., Chanock R. M. A complement-fixation test for measuring Australia antigen and antibody. J Infect Dis. 1969 Sep;120(3):383–386. doi: 10.1093/infdis/120.3.383. [DOI] [PubMed] [Google Scholar]
  48. Redeker A. G., Yamahiro H. S. Viral hepatitis. Current concepts. Postgrad Med. 1967 Jan;41(1):21–29. doi: 10.1080/00325481.1967.11696098. [DOI] [PubMed] [Google Scholar]
  49. Reed W., Lucas Z. J., Kempson R., Cohn R. Renal transplantation in patients with Australia antigenemia. Transplant Proc. 1971 Mar;3(1):343–346. [PubMed] [Google Scholar]
  50. SEVER J. L. Application of a microtechnique to viral serological investigations. J Immunol. 1962 Mar;88:320–329. [PubMed] [Google Scholar]
  51. STARZL T. E., MARCHIORO T. L., PORTER K. A., TAYLOR P. D., FARIS T. D., HERRMANN T. J., HLAD C. J., WADDELL W. R. FACTORS DETERMINING SHORT- AND LONG-TERM SURVIVAL AFTER ORTHOTOPIC LIVER HOMOTRANSPLANTATION IN THE DOG. Surgery. 1965 Jul;58:131–155. [PMC free article] [PubMed] [Google Scholar]
  52. STARZL T. E., MARCHIORO T. L., ROWLANDS D. T., Jr, KIRKPATRICK C. H., WILSON W. E., RIFKIND D., WADDELL W. R. IMMUNOSUPPRESSION AFTER EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER. Ann Surg. 1964 Sep;160:411–439. doi: 10.1097/00000658-196409000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. SUTTON W. R., GRIFFITH H. B., PRESTON F. W. Effect of cancer chemotherapeutic agents on the survival of homografts of skin. Surg Forum. 1961;12:117–118. [PubMed] [Google Scholar]
  54. Shulman N. R., Barker L. F. Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation. Science. 1969 Jul 18;165(3890):304–306. doi: 10.1126/science.165.3890.304. [DOI] [PubMed] [Google Scholar]
  55. Starzl T. E., Giles G., Lilly J. R., Takagi H., Martineau G., Schroter G., Halgrimson C. G., Penn I., Putnam C. W. Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis. Transplant Proc. 1971 Mar;3(1):308–312. [PMC free article] [PubMed] [Google Scholar]
  56. Starzl T. E., Porter K. A., Andres G., Halgrimson C. G., Hurwitz R., Giles G., Terasaki P. I., Penn I., Schroter G. T., Lilly J. Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg. 1970 Sep;172(3):437–472. doi: 10.1097/00000658-197009000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Sutnick A. I., London W. T., Gerstley B. J., Cronlund M. M., Blumberg B. S. Anicteric hepatitis associated with Australia antigen. Occurrence in patients with Down's syndrome. JAMA. 1968 Sep 2;205(10):670–674. [PubMed] [Google Scholar]
  58. Tamura N., Nelson R. A., Jr Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum. J Immunol. 1967 Sep;99(3):582–589. [PubMed] [Google Scholar]
  59. Torisu M., Arata M., Sonozaki H., Majima H. C'3c deficient human sera with a beta-1c precipitin line. J Immunol. 1967 Sep;99(3):629–636. [PubMed] [Google Scholar]
  60. Torisu M., Sonozaki H., Shiraishi S., Nishioka K. Purification of C'3 inactivator from human serum. Nature. 1968 Jun 22;218(5147):1163–1164. doi: 10.1038/2181163a0. [DOI] [PubMed] [Google Scholar]
  61. Willems F. T., Kunst V. A., Rosier J. G. Complement-fixation test for Australia antigen. Lancet. 1970 May 2;1(7653):953–953. doi: 10.1016/s0140-6736(70)91083-4. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES